MwanzoSHTDY • OTCMKTS
add
Sinopharm Group ADR
$ 13.26
Baada ya Saa za Kazi:(0.27%)+0.036
$ 13.30
Imefungwa: 2 Apr, 16:00:01 GMT -4 · USD · OTCMKTS · Kanusho
Bei iliyotangulia
$ 13.00
Bei za siku
$ 13.26 - $ 13.36
Bei za mwaka
$ 10.77 - $ 14.87
Thamani ya kampuni katika soko
65.28B HKD
Wastani wa hisa zilizouzwa
elfu 78.07
Uwiano wa bei na mapato
-
Mgao wa faida
-
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CNY) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 143.69B | 1.13% |
Matumizi ya uendeshaji wa biashara | 5.00B | -10.42% |
Mapato halisi | 1.85B | 4.36% |
Kiwango cha faida halisi | 1.29 | 3.20% |
Mapato kwa kila hisa | — | — |
EBITDA | 5.97B | -2.51% |
Asilimia ya kodi ya mapato | 30.30% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CNY) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 48.80B | -10.16% |
Jumla ya mali | 390.36B | -0.63% |
Jumla ya dhima | 256.20B | -3.74% |
Jumla ya hisa | 134.16B | — |
hisa zilizosalia | 3.12B | — |
Uwiano wa bei na thamani | 0.48 | — |
Faida inayotokana na mali | 3.34% | — |
Faida inayotokana mtaji | 6.42% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CNY) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 1.85B | 4.36% |
Pesa kutokana na shughuli | 53.22B | -10.21% |
Pesa kutokana na uwekezaji | -1.21B | 67.09% |
Pesa kutokana na ufadhili | -30.23B | 18.95% |
Mabadiliko halisi ya pesa taslimu | 21.77B | 19.12% |
Mtiririko huru wa pesa | 24.05B | — |
Kuhusu
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Ilianzishwa
2003
Tovuti
Wafanyakazi
94,910
